Yunxiang Chu
About
In The Last Decade
Yunxiang Chu
16 papers receiving 665 citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 247
- Neurology 201
- Immunology 183
- Cellular and Molecular Neuroscience 114
- Cancer Research 106
Countries citing papers authored by Yunxiang Chu
This map shows the geographic impact of Yunxiang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunxiang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunxiang Chu more than expected).
Fields of papers citing papers by Yunxiang Chu
This network shows the impact of papers produced by Yunxiang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunxiang Chu. The network helps show where Yunxiang Chu may publish in the future.
Co-authorship network of co-authors of Yunxiang Chu
This figure shows the co-authorship network connecting the top 25 collaborators of Yunxiang Chu. A scholar is included among the top collaborators of Yunxiang Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunxiang Chu. Yunxiang Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 28 | |
| 3 | 5 | |
| 4 | 17 | |
| 5 | 9 | |
| 6 | 16 | |
| 7 | [Non-bismuth quadruple therapy versus standard triple therapy for Helicobacter pylori eradication: a randomized controlled study]. | 3 |
| 8 | 140 | |
| 9 | 296 | |
| 10 | 51 | |
| 11 | 92 | |
| 12 | 10 | |
| 13 | [Sequential intensified immunosuppressive therapy combining with hematopoietic growth factors in the treatment of severe aplastic anemia]. | 4 |
| 14 | [The clinical implications of IgG subclass in 84 patients with autoimmune hemolytic anemia]. | 6 |
| 15 | [Antilymphocyte globulin combining with cyclosporine A in the treatment of severe aplastic anemia]. | 2 |
| 16 | [Clinical analysis of 164 cases Coombs test positive autoimmune hemolytic anemia]. | 1 |
| 17 | [Correlation between the serum levels of interleukin-2 and soluble interleukin-2 receptor and the response to immunosuppressive therapy in severe aplastic anemia patients]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.